Company / Operating Income
Vericel Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$11.0M
FY2025
5-year range
-$11.3M / $11.0M
FY2021-FY2025
Trend
+144.4%
vs FY2024
Sector context
#54 of 204
Health Care
What the data says
At $11M, Vericel's operating income ranks #54 of 204 in the Health Care sector. Operating Income has fluctuated over the past 10 years, ranging from -$24M in FY2016 to $11M in FY2025.
Based on SEC 10-K filings.
$11M in FY2025 with a 3-year CAGR of +67.0%.
Improved from -$6M to $11M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +67.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#54 of 204 in Health CareTop 26% of 204This company $11.0M Sector average $107.7M
▼
-89.7% below sector average
Key checks
Key Insights
- 3-year CAGR of +67.0%, indicating consistent growth.
- In FY2025, operating income increased 144.4% year-over-year.
- Ranks #54 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.0M | +144.4% |
| FY2024 | $4.5M | +169.9% |
| FY2023 | -$6.5M | -372.5% |
| FY2022 | $2.4M | +121.1% |
| FY2021 | -$11.3M | -187.8% |
| FY2020 | -$3.9M | +73.9% |
| FY2019 | -$15.0M | +22.1% |
| FY2018 | -$19.2M | -15.4% |
| FY2017 | -$16.7M | +29.2% |
| FY2016 | -$23.5M | -12.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026